论文信息 - Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer. - 字舞流文

Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer.

E. Schuuring | E. Smit | K. Monkhorst | A. D. de Langen | D. Heideman | M. Groves | A. J. Langen | A. van der Wekken | T. Radonic | M. Paats | S. Hashemi | B. van Veggel | J.F. Vilacha Madeira R Santos | A. Wekken | Egbert F. Smit | E. Schuuring | M. R. Groves | Sayed M. S. Hashemi | Daniëlle A.M. Heideman | B. V. Veggel | J. F. V. M. R. Santos